ABT — Abbott Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual balance sheet for Abbott Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	fx Preliminary
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,249	10,170	7,279	7,967	—
Net Total Accounts Receivable
Net Total Receivables	6,487	6,218	6,565	6,925	—
Total Inventory
Prepaid Expenses
Total Current Assets	24,239	25,224	22,670	23,656	—
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,112	10,278	11,276	11,733	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	75,196	74,438	73,214	81,414	—
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,105	15,489	13,841	14,157	—
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	39,394	37,752	34,611	33,750	—
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	35,802	36,686	38,603	47,664	—
Total Liabilities & Shareholders' Equity	75,196	74,438	73,214	81,414	—
Total Common Shares Outstanding